Total Payments
$16,592
2024 Payments
$2,374
Companies
37
Transactions
1,162
Medicare Patients
7,202
Medicare Billing
$524,145
Payment Breakdown by Category
Food & Beverage$16,479 (99.3%)
Education$113.54 (0.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,479 | 1,156 | 99.3% |
| Education | $113.54 | 6 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,478 | 221 | $0 (2024) |
| PFIZER INC. | $1,507 | 110 | $0 (2024) |
| Amgen Inc. | $1,499 | 81 | $0 (2024) |
| Lilly USA, LLC | $1,165 | 68 | $0 (2024) |
| Janssen Biotech, Inc. | $1,151 | 107 | $0 (2024) |
| UCB, Inc. | $908.37 | 72 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $845.23 | 43 | $0 (2024) |
| Celgene Corporation | $738.98 | 63 | $0 (2019) |
| LEO Pharma Inc. | $663.34 | 38 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $659.84 | 48 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,374 | 156 | ABBVIE INC. ($644.06) |
| 2023 | $1,782 | 116 | Amgen Inc. ($300.02) |
| 2022 | $2,172 | 145 | ABBVIE INC. ($539.90) |
| 2021 | $2,318 | 152 | AbbVie Inc. ($454.71) |
| 2020 | $2,314 | 140 | AbbVie Inc. ($409.76) |
| 2019 | $2,395 | 191 | AbbVie, Inc. ($449.31) |
| 2018 | $1,682 | 130 | AbbVie, Inc. ($454.46) |
| 2017 | $1,556 | 132 | AbbVie, Inc. ($283.23) |
All Payment Transactions
1,162 individual payment records from CMS Open Payments — Page 1 of 47
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | — | Education | In-kind items and services | $8.45 | General |
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.63 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $10.80 | General |
| Category: Immunology | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $2.75 | General |
| Category: Immunology | ||||||
| 12/12/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $3.65 | General |
| Category: DERMATOLOGY | ||||||
| 12/10/2024 | Lilly USA, LLC | TALTZ (Drug), ZEPBOUND, EBGLYSS | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Immunology | ||||||
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $2.47 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $8.78 | General |
| Category: DERMATOLOGY | ||||||
| 12/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/04/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $26.30 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $8.03 | General |
| Category: Immunology | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $1.06 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.56 | General |
| Category: DERMATOLOGY | ||||||
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.50 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $5.41 | General |
| Category: DERMATOLOGY | ||||||
| 11/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.22 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $22.55 | General |
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $5.47 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $5.13 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.26 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,916 | 4,118 | $519,630 | $140,555 |
| 2022 | 14 | 1,889 | 3,829 | $485,245 | $134,657 |
| 2021 | 16 | 1,781 | 3,147 | $443,390 | $140,257 |
| 2020 | 13 | 1,616 | 2,764 | $377,395 | $108,676 |
Total Patients
7,202
Total Services
13,858
Medicare Billing
$524,145
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 807 | 1,105 | $142,765 | $64,832 | 45.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 385 | 489 | $61,855 | $20,197 | 32.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 160 | 190 | $38,210 | $13,565 | 35.5% |
| 11606 | Removal of cancer skin growth of body, arms, or legs, more than 4.0 cm | Office | 2023 | 24 | 31 | $26,180 | $10,726 | 41.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 288 | 1,994 | $183,525 | $9,257 | 5.0% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 42 | 59 | $23,100 | $8,006 | 34.7% |
| 11604 | Removal of cancer skin growth of body, arms, or legs, 3.1-4.0 cm | Office | 2023 | 16 | 18 | $11,550 | $4,192 | 36.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 90 | 90 | $13,060 | $3,684 | 28.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 45 | 79 | $7,900 | $3,041 | 38.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 22 | 23 | $6,325 | $1,870 | 29.6% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 13 | 15 | $1,740 | $604.92 | 34.8% |
| 69100 | Biopsy of ear | Office | 2023 | 11 | 11 | $3,350 | $569.40 | 17.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 13 | 14 | $70.00 | $12.15 | 17.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 773 | 1,092 | $136,500 | $62,657 | 45.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 371 | 473 | $59,125 | $19,387 | 32.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 197 | 226 | $41,810 | $16,342 | 39.1% |
| 11606 | Removal of cancer skin growth of body, arms, or legs, more than 4.0 cm | Office | 2022 | 25 | 32 | $26,880 | $11,184 | 41.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 262 | 1,691 | $169,100 | $7,476 | 4.4% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 35 | 48 | $16,800 | $6,890 | 41.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 61 | 95 | $9,500 | $3,700 | 38.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 73 | 73 | $10,585 | $2,682 | 25.3% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 13 | 13 | $2,925 | $1,069 | 36.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 14 | 15 | $4,125 | $1,051 | 25.5% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2022 | 13 | 13 | $1,950 | $825.83 | 42.4% |
| 69100 | Biopsy of ear | Office | 2022 | 12 | 12 | $3,300 | $694.76 | 21.1% |
About Dr. Laura Wagner, M.D
Dr. Laura Wagner, M.D is a Specialist healthcare provider based in Chesterfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669445060.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Laura Wagner, M.D has received a total of $16,592 in payments from pharmaceutical and medical device companies, with $2,374 received in 2024. These payments were reported across 1,162 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($16,479).
As a Medicare-enrolled provider, Wagner has provided services to 7,202 Medicare beneficiaries, totaling 13,858 services with total Medicare billing of $524,145. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Chesterfield, MO
- Active Since 02/08/2006
- Last Updated 05/24/2012
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1669445060
Products in Payments
- Otezla (Drug) $1,504
- SKYRIZI (Biological) $1,423
- EUCRISA (Drug) $1,417
- TALTZ (Drug) $1,165
- Humira (Biological) $1,127
- Cimzia (Drug) $701.51
- Sotyktu (Drug) $651.70
- VTAMA (Drug) $552.51
- DUPIXENT (Biological) $550.26
- RINVOQ (Biological) $509.39
- ENSTILAR (Drug) $492.28
- TREMFYA (Drug) $409.71
- HUMIRA (Biological) $310.73
- Tremfya (Drug) $286.02
- COSENTYX (Biological) $280.90
- ILUMYA (Biological) $255.04
- REMICADE (Biological) $244.46
- DORYX (Drug) $220.38
- STELARA (Biological) $210.57
- Bimzelx (Biological) $206.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Chesterfield
Dr. Matthew Gornet, M.d, M.D
Specialist — Payments: $355,559
Specialist $355,559
Jay Pepose, M.d, M.D
Specialist — Payments: $217,277
Specialist $217,277
Dr. Herluf Lund, Md, MD
Specialist — Payments: $66,508
Specialist $66,508
Dr. Christian Prada, M.d, M.D
Specialist — Payments: $43,068
Specialist $43,068
Mrs. Judith Gurley, M.d., F.a.c.s, M.D., F.A.C.S
Specialist — Payments: $12,113
Specialist $12,113
Dr. John Krause, M.d, M.D
Specialist — Payments: $6,158
Specialist $6,158